Company registration number 08330901 (England and Wales)
KENT HEART DOCTOR LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
KENT HEART DOCTOR LTD
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 5
KENT HEART DOCTOR LTD
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
30,105
31,043
Current assets
Debtors
5
25,083
18,617
Cash at bank and in hand
1,001,842
940,692
1,026,925
959,309
Creditors: amounts falling due within one year
6
(53,084)
(47,621)
Net current assets
973,841
911,688
Total assets less current liabilities
1,003,946
942,731
Provisions for liabilities
(7,526)
(7,761)
Net assets
996,420
934,970
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
996,320
934,870
Total equity
996,420
934,970

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 22 September 2026 and are signed on its behalf by:
Dr E  Fountzopoulos
Director
Company registration number 08330901 (England and Wales)
KENT HEART DOCTOR LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

Kent Heart Doctor Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Globe House, Eclipse Park, Sittingbourne Road, Maidstone, Kent, United Kingdom, ME14 3EN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business.

Revenue from contracts for the provision of professional services is recognised in the period in which the services are provided, by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
20% Straight line basis
Motor vehicles
25% Reducing balance basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments
Basic financial assets

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loan from banks and other third parties, loans to related parties and investments in ordinary shares.

KENT HEART DOCTOR LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of future cash flows and subsequently at amortised cost using the effective rate method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially, and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

KENT HEART DOCTOR LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
4
Tangible fixed assets
Fixtures and fittings
Motor vehicles
Total
£
£
£
Cost
At 1 January 2025
5,961
92,967
98,928
Additions
8,109
-
0
8,109
At 31 December 2025
14,070
92,967
107,037
Depreciation and impairment
At 1 January 2025
2,951
64,934
67,885
Depreciation charged in the year
2,039
7,008
9,047
At 31 December 2025
4,990
71,942
76,932
Carrying amount
At 31 December 2025
9,080
21,025
30,105
At 31 December 2024
3,010
28,033
31,043
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
18,800
12,000
Other debtors
6,283
6,617
25,083
18,617
KENT HEART DOCTOR LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
46,476
39,254
Other taxation and social security
2,126
-
0
Other creditors
4,482
8,367
53,084
47,621
2025-12-312025-01-01falsefalsefalse22 September 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityDr E FountzopoulosMrs M FountzopoulosMrs M Fountzopoulos083309012025-01-012025-12-31083309012025-12-31083309012024-12-3108330901core:FurnitureFittings2025-12-3108330901core:MotorVehicles2025-12-3108330901core:FurnitureFittings2024-12-3108330901core:MotorVehicles2024-12-3108330901core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3108330901core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3108330901core:WithinOneYear2025-12-3108330901core:WithinOneYear2024-12-3108330901core:CurrentFinancialInstruments2025-12-3108330901core:CurrentFinancialInstruments2024-12-3108330901core:ShareCapital2025-12-3108330901core:ShareCapital2024-12-3108330901core:RetainedEarningsAccumulatedLosses2025-12-3108330901core:RetainedEarningsAccumulatedLosses2024-12-3108330901bus:Director12025-01-012025-12-3108330901core:FurnitureFittings2025-01-012025-12-3108330901core:MotorVehicles2025-01-012025-12-31083309012024-01-012024-12-3108330901core:FurnitureFittings2024-12-3108330901core:MotorVehicles2024-12-31083309012024-12-3108330901bus:PrivateLimitedCompanyLtd2025-01-012025-12-3108330901bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3108330901bus:FRS1022025-01-012025-12-3108330901bus:AuditExemptWithAccountantsReport2025-01-012025-12-3108330901bus:Director22025-01-012025-12-3108330901bus:CompanySecretary12025-01-012025-12-3108330901bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP